Bram Verstockt

115PUBLICATIONS
296CO-AUTHORS
Innate immunityMolecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Rheumatology and arthritis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (115)

|Sep 25, 2026
Distinct intestinal eosinophil subsets in ulcerative colitis and their modulation by advanced inflammatory bowel disease therapies.

|Sep 11, 2026
Bridging preclinical and clinical efficacy of SIK2/SIK3 inhibition in inflammatory bowel disease through integrated murine, patient-derived models, and phase 2a trial-based analyses.

|Sep 11, 2026
Isolated perianal fistulizing Crohn's disease in contemporary clinical practice: a multicenter ECCO-CONFER cohort study.

|Aug 18, 2026
Positioning Guselkumab in The Treatment Algorithm for Ulcerative Colitis.

|Aug 09, 2026
Characterization of remission levels in patients with ulcerative colitis treated with 5-aminosalicylates: results of the cross-sectional CARUC-ASA study by the Belgian IBD Research and Development Group.

|Jul 23, 2026
Patient Preferences for Inflammatory Bowel Disease Treatment: Results from a Global Survey Conducted in Partnership with the European Federation of Crohn's & Ulcerative Colitis Associations.

Pageof 20

Frequent Collaborators

38 joint publications

Séverine Vermeire

28 joint publications

Marc Ferrante

11 joint publications

Nurulamin Noor

9 joint publications

Sare Verstockt